Celularity raises $250M to develop cell therapies: CEO

Peter Diamandis, Celularity co-founder and vice chairman, and Bob Hariri, Celularity co-founder, chairman and CEO, talk about the future of cellular medicine as scientist develop ways to reengineer living cells.